Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 2549 of 5804
-
New nasal spray could take the edge off public speaking anxiety
Symptom relief Recruiting nowThis U.S. multicenter, double-blind, placebo-controlled Phase 2 clinical trial is designed to evaluate the efficacy, safety, and tolerability of a repeat intranasal (i.n.) dose of Fasedienol Nasal Spray (fasedienol) (3.2 µg) to relieve symptoms of acute anxiety in adult subjects …
Phase: PHASE2 • Sponsor: VistaGen Therapeutics, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 09:02 UTC
-
Ear zaps may speed stroke arm recovery
Symptom relief Recruiting nowThis randomized pilot clinical study aims to investigate the effects of trans-auricular vagus nerve stimulation (tVNS) on neuromotor recovery in patients in the subacute phase after stroke. Participants admitted for intensive rehabilitation at ICS Maugeri Centers (Montescano, Pav…
Phase: NA • Sponsor: Istituti Clinici Scientifici Maugeri SpA • Aim: Symptom relief
Last updated Jun 27, 2026 12:32 UTC
-
Light therapy mask may soothe dry eyes after cataract surgery
Symptom relief CompletedThis randomized, controlled clinical trial investigates the perioperative use of low-level light therapy (LLLT) to prevent or reduce signs and symptoms of dry eye disease (DED) in patients undergoing cataract surgery. DED is a prevalent postoperative complication associated with …
Phase: NA • Sponsor: Grigore T. Popa University of Medicine and Pharmacy • Aim: Symptom relief
Last updated Jun 27, 2026 08:08 UTC
-
New diabetes drug SHR-3167 takes on insulin in Head-to-Head trial
Disease control CompletedThe purpose of this study is to evaluate the efficacy and safety of SHR-3167 compared with insulin glargine after treatment in insulin naïve subjects with type 2 diabetes treated with metformin alone or in combination with SGLT2 subjects.
Phase: PHASE2 • Sponsor: Jiangsu HengRui Medicine Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 13:03 UTC
-
VR brain training at home could slow memory loss
Symptom relief Recruiting nowThe goal of this clinical trial is to evaluate the effectiveness of a telerehabilitation program combined with a virtual reality (VR) app in improving cognitive performance and social skills in patients with Subjective Cognitive Decline (SCD) and Mild Cognitive Impairment (MCI). …
Phase: NA • Sponsor: IRCCS Centro Neurolesi Bonino Pulejo • Aim: Symptom relief
Last updated Jun 27, 2026 12:03 UTC
-
Flozins under the microscope: can they protect heart and kidneys in High-Risk patients?
Knowledge-focused Recruiting nowThe main aim of this study is to holistically assess the cardiovascular and renal outcomes in HFpEF CKD patients with and without SGLT2 inhibition, with focus on the endothelial disfunction, MACE and mortality using clinical evaluation, flow mediated dilatation, carotid-femoral p…
Sponsor: Grigore T. Popa University of Medicine and Pharmacy • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:58 UTC
-
Time travel in VR: could 1960s scenes revive memories in Alzheimer's?
Symptom relief CompletedThis study aims to evaluate whether immersive virtual reality (VR) can improve cognitive function and memory in patients with Alzheimer's disease. Twenty participants in Burgos, Spain, will engage in VR sessions that recreate scenes from 1960s Burgos, representing environments fa…
Phase: NA • Sponsor: Universidad de Burgos • Aim: Symptom relief
Last updated Jun 27, 2026 13:07 UTC
-
New targeted drug LNCB74 enters human trials for Hard-to-Treat cancers
Disease control Recruiting nowThis is an open-label, phase 1, dose escalation and dose expansion study to determine safety and tolerability, and to determine the maximum tolerated dose and / or recommended phase 2 dose of LNCB74 in participants with advanced solid tumors.
Phase: PHASE1 • Sponsor: NextCure, Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
New staph vaccine shows promise in early human trial
⭐️ VACCINE ⭐️ CompletedIn this study, the candidate vaccine LTB-SA7 will be tested for safety and immunogenicity in healthy adults.
Phase: PHASE1 • Sponsor: LimmaTech Biologics AG • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 11:03 UTC
-
Herbal GLP-1 booster shows promise for weight loss and blood sugar in small trial
Disease control CompletedBACKGROUND GLP1 booster (GB) was designed to stimulate the endogenous production of GLP1, which in turn releases insulin, controls blood glucose level, suppresses appetite and thus helps people lose weight. PURPOSE In prior study, GB was clinically shown to reduce blood sugar le…
Phase: NA • Sponsor: Lawry Han • Aim: Disease control
Last updated Jun 26, 2026 13:02 UTC
-
Surgery vs. botox: which works better for stiff muscles?
Disease control Recruiting nowSpasticity is a common complication following central nervous system injuries. Left untreated, spasticity can lead to various complications, hindering activities of daily living and diminishing independence. Spasticity affecting the hand is particularly debilitating because it pr…
Phase: NA • Sponsor: Vastra Gotaland Region • Aim: Disease control
Last updated Jun 26, 2026 18:24 UTC
-
Blood flow trick may boost balance in Parkinson's patients
Symptom relief Recruiting nowThis study is being done to understand how reducing blood flow (BRT) during balance-challenging strengthening exercises (instability resistance training, or IRT) can help improve symptoms of Parkinson's disease.
Phase: NA • Sponsor: The University of Texas Health Science Center at San Antonio • Aim: Symptom relief
Last updated Jun 27, 2026 12:01 UTC
-
Pre-Surgery nutrition shakes may cut complications for IBD patients
Disease control Recruiting nowThis study aims to determine if improved risk stratification tools and interventions to mitigate malnutrition reduce postoperative risk in patients undergoing elective or emergent resection surgery for inflammatory bowel disease (IBD), and if adding immune modulation nutrition im…
Phase: NA • Sponsor: NYU Langone Health • Aim: Disease control
Last updated Jun 27, 2026 09:11 UTC
-
Danish website aims to improve youth mental health – does it work?
Knowledge-focused CompletedIn a two-armed randomized controlled trial 15-25-year-olds will be recruited via social media to evaluate the effectiveness of Mindhelper.dk; a Danish self-guided, digital, mental health service offering information, self-help tools, and guidance to young people. Participants wil…
Phase: NA • Sponsor: University of Southern Denmark • Aim: Knowledge-focused
Last updated Jul 25, 2026 00:00 UTC
-
Sound waves aim to ease Parkinson's tremors
Symptom relief CompletedRandomized, double-blind, self-cross-over control (After the first visit, patients are divided into two groups, randomly receiving real stimulation/placebo stimulation. 14 days later, during the second visit, a cross-over occurs: patients who received real stimulation in the firs…
Phase: NA • Sponsor: Xinhua Hospital, Shanghai Jiao Tong University School of Medicine • Aim: Symptom relief
Last updated Jun 27, 2026 12:38 UTC
-
New program aims to keep patients on track after Infection-Related hospitalizations
Disease control CompletedThis project is a pilot study of an adapted intervention of an existing Opioid Use Disorder (OUD) treatment retention intervention called Recovery Management Checkups (RMC). This intervention has been adapted to better fit the experiences and unique issues of those that have been…
Phase: NA • Sponsor: Boston Medical Center • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
Hospital walking program aims to fight frailty in heart patients
Symptom relief Recruiting nowFrailty describes the overall health of a person. Inpatients with cardiovascular problems have a higher risk for frailty - or the sick are more likely to get sicker - causing longer hospital stays, hospital readmission, and death. Females are particularly vulnerable to these prob…
Phase: NA • Sponsor: Université de Sherbrooke • Aim: Symptom relief
Last updated Jun 27, 2026 12:29 UTC
-
New combo shot aims to simplify type 2 diabetes management
Disease control CompletedThis is an intervention, phase IV, single-arm study to assess the safety and efficacy of iGlarLixi in adult patients with Type 2 diabetes.
Phase: PHASE4 • Sponsor: Sanofi • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
Can watching someone eat help you swallow again? new stroke therapy shows promise
Symptom relief Recruiting nowDysphagia is one of the most common symptoms of stroke patients, which seriously affects the quality of life of patients and delays the progress of rehabilitation. At present, the commonly used clinical swallowing treatment methods can achieve certain therapeutic effects, but the…
Phase: NA • Sponsor: Qilu Hospital of Shandong University • Aim: Symptom relief
Last updated Jun 27, 2026 07:51 UTC
-
New pill helps dialysis patients control dangerous phosphorus levels
Disease control CompletedA phase 3, randomized, placebo-controlled, double-blind study of TS-172 in hyperphosphatemia
Phase: PHASE3 • Sponsor: Taisho Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC